Announcements and Notices - [Other - Business Update]

Lee's Pharmaceutical Holdings Limited develops, manufactures and sells quality biopharmaceutical products that focus on combating cardiovascular diseases and viral sexually transmitted diseases.

Voluntary Announcement - Potential Acceptance Notice Of Investigational New Drug Application Of Recombinant Anfibatide Injection

Notification Letter And Reply Form To Non-Registered Shareholders - Notice Of Publication Of Interim Report

Notification Letter And Reply Form To Registered Shareholders - Notice Of Publication Of Interim Report

Financial Statements/ESG Information - [Interim/Half-Year Report]

Interm Report 2024

Announcements and Notices - [Dividend or Distribution (Announcement Form)]

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Lee's Pharmaceutical (950 HK)

Voluntary Announcement - Potential Acceptance Notice Of Investigational New Drug Application Of Recombinant Anfibatide Injection

Notification Letter And Reply Form To Non-Registered Shareholders - Notice Of Publication Of Interim Report

Notification Letter And Reply Form To Registered Shareholders - Notice Of Publication Of Interim Report

Interm Report 2024

Interim Dividend For The Six Months Ended 30 June 2024

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)